Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2013 Dec 21;112(2):116–120. doi: 10.1016/j.anai.2013.11.021

Table 1.

Comparison of Potential Factors Between Low Adherence versus High Adherence Groups

Total (n=93) Low Adherence (≤48%) (n=68) High Adherence (>48%) (n=25) p value
DEMOGRAPHIC
Age Mean (Min, Max) 13.2 (10, 16) 13.4 (11,16) 12.4 (10, 16) 0.012
Gender, n (%)
 Male 41 (44.1) 35 (51.5) 6 (24.0) 0.020
 Female 52 (55.9) 33 (48.5) 19 (76.0)
Ethnicity: Hispanic/Latino, n (%) 10 (10.8) 8 (11.8) 2 (8.0) 0.724
Race, n (%)
 Black/African American 82 (88.1) 59 (86.8) 23 (92.0) 0.797
 Mixed African American* 1 (1.1) 1 (1.5) 0 (0.0)
 Other 10 (10.8) 8 (11.8) 2 (8.0)
Child insurance status, n (%)
 Public 70 (75.3) 53 (77.9) 17 (68.0) 0.417
 Private 23 (24.7) 15 (22.1) 8 (32.0)
Receive free or reduced school lunch, n (%) 76 (84.4) 55 (82.1) 21 (91.3) 0.505
ASTHMA
Asthma controller medications, n (%)
 ICS monotherapy 71 (76.3) 51 (75.0) 20 (80.0) 0.785
 ICS and long-acting bronchodilator combination therapy 22 (23.7) 17 (25.0) 5 (20.0)
Smoking behavior reported by adolescent, n (%)
 Current smoker 2 (2.1) 2 (2.9) 0 (0.0) >0.999
 Exposed to second hand smoke at home 6 (6.5) 5 (7.4) 1 (4.0) >0.999
ZAP Asthma Knowledge Instrument
 % items correct, median (Q1, Q3) 69.2 (61.5, 74.4) 69.2 (61.6, 76.9) 66.7 (61.5, 71.8) 0.260
ICS Knowledge Questionnaire, median (Q1, Q3) 25.0 (23.0, 27.0) 24.0 (22.0, 26.0) 26.0 (24.0, 29.0) <0.001
PSYCHOSOCIAL
Children’s Depression Inventory 2 n, (%)
 Very elevated 15 (16.1) 11 (16.2) 4 (16.0) 0.976
 Elevated 6 (6.5) 4 (5.9) 2 (8.0)
 High average 11 (11.8) 8 (11.8) 3 (12.0)
 Average or lower 61 (65.6) 45 (66.2) 16 (64.0)
ICS Self-Efficacy Questionnaire, median (Q1, Q3) 53.0 (47.0, 59.0) 51.5 (46.5, 59.0) 55.0 (49.0, 60.0) 0.245
*

Mixed African American: Self-identified as a combination of African American and another race

Criteria for Free and Reduced School Lunch in Chicago Public Schools July 1, 2011 - June 30, 2012. Source: http://www.fns.usda.gov/cnd/governance/notices/iegs/IEGs11-12.pdf

Inhaled corticosteroid and long-acting bronchodilator: Two participants who were taking Inhaled Corticosteroid and Long Acting Bronchodilator Combination Therapy were also taking Inhaled Corticosteroid Monotherapy